Pavan Lall And Sohini Das

Stories by Pavan Lall And Sohini Das

Premium carmakers caught in a bind over high taxes

Premium carmakers caught in a bind over high taxes

Rediff.com   3 Nov 2020

Automakers are caught in a chicken-and-egg situation: Prices have to come down if volumes are to increase, and volumes won't increase unless prices come down, notes Pavan Lall.

Bharat Biotech starts Covaxin's at-risk manufacture

Bharat Biotech starts Covaxin's at-risk manufacture

Rediff.com   2 Nov 2020

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results.

Why Dr Reddy's had to shut all its units

Why Dr Reddy's had to shut all its units

Rediff.com   25 Oct 2020

Security breach came days after the firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V.

Why India's automobile business is like Bollywood

Why India's automobile business is like Bollywood

Rediff.com   20 Oct 2020

What worked for Hyundai in India when so many other auto manufacturers have had to eat humble pie? Pavan Lall finds out.

Covid-19 impact: Low interest loans likely for vaccine companies

Covid-19 impact: Low interest loans likely for vaccine companies

Rediff.com   10 Oct 2020

While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made available to these players only when the time to scale up manufacturing arises.

Covaxin: How Bharat Biotech plans to boost immunity

Covaxin: How Bharat Biotech plans to boost immunity

Rediff.com   6 Oct 2020

Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed.

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Rediff.com   6 Oct 2020

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com   6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

Homestays come to travellers' aid in Covid times

Homestays come to travellers' aid in Covid times

Rediff.com   27 Sep 2020

Intimate getaways offered in the form of homestays by hotels are proving to be the flavour of this extraordinary and difficult time. Not far from cities, they offer a pleasant respite from homebound lives, says Pavan Lall.

The Kia Sonet is on song

The Kia Sonet is on song

Rediff.com   25 Sep 2020

On the highway, it pulls along with ease and offers smooth commuter ride and drive experience, and also has little competition, says Pavan Lall.

How India is gearing up to distribute Covid-19 vaccine

How India is gearing up to distribute Covid-19 vaccine

Rediff.com   18 Sep 2020

A model being considered is to have a combined cold chain approach - where the agricultural cold chain would be combined with vaccine cold chains.

Volkswagen T-Roc: In the presence of true power

Volkswagen T-Roc: In the presence of true power

Rediff.com   16 Sep 2020

Quality-wise, and on the fun-to-drive scale, the T-Roc is in a league of its own, notes Pavan Lall.

Labs bet on Covid tests for next growth phase

Labs bet on Covid tests for next growth phase

Rediff.com   14 Sep 2020

The bouquet of Covid-19 tests that most diagnostic labs are offering include antibody tests (blood tests), rapid antigen tests (point of care tests that detect the presence of an antigen from a nasal or throat swab in case of SARS-CoV-2), and reverse transcription-polymerase chain reaction (RT-PCR) tests.

Power suit bows out as WFH hits office dress code

Power suit bows out as WFH hits office dress code

Rediff.com   13 Sep 2020

Master tailors, textile manufacturers and custom clothiers, however, say the upcoming festive season, reinvention in the form of new collections and digital outreach are salvaging the situation somewhat.

India will wait for DCGI nod to restart Oxford vaccine trial

India will wait for DCGI nod to restart Oxford vaccine trial

Rediff.com   11 Sep 2020

The global trials were halted after a study participant suffered a 'potentially unexplained illness, reports Sohini Das.

With coronavirus still around, 'virus killers' hit the market

With coronavirus still around, 'virus killers' hit the market

Rediff.com   7 Sep 2020

A gamechanger for offices and factories, Shycocan, claims to be able to clear an area of 1000 square feet from coronavirus.

In the works: Priority list of who will get Covid vaccine first

In the works: Priority list of who will get Covid vaccine first

Rediff.com   4 Sep 2020

The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready.

Indian pharma firms working on new repurposed drug for Covid-19

Indian pharma firms working on new repurposed drug for Covid-19

Rediff.com   2 Sep 2020

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.

Want to be a professional drone pilot?

Want to be a professional drone pilot?

Rediff.com   27 Aug 2020

There's a need to train 40,000 pilots over the next year-and-a-half.

Pandemic brings windfall for e-pharma companies

Pandemic brings windfall for e-pharma companies

Rediff.com   27 Aug 2020

The online pharmacy market, which was worth about $512 million in 2018, is growing at a CAGR of 63 per cent and is expected to hit overall revenues of over $3.6 billion by 2022.